248 related articles for article (PubMed ID: 20959290)
1. Regulation of the androgen receptor by SET9-mediated methylation.
Gaughan L; Stockley J; Wang N; McCracken SR; Treumann A; Armstrong K; Shaheen F; Watt K; McEwan IJ; Wang C; Pestell RG; Robson CN
Nucleic Acids Res; 2011 Mar; 39(4):1266-79. PubMed ID: 20959290
[TBL] [Abstract][Full Text] [Related]
2. Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase.
Ko S; Ahn J; Song CS; Kim S; Knapczyk-Stwora K; Chatterjee B
Mol Endocrinol; 2011 Mar; 25(3):433-44. PubMed ID: 21273441
[TBL] [Abstract][Full Text] [Related]
3. The histone methyltransferase, NSD2, enhances androgen receptor-mediated transcription.
Kang HB; Choi Y; Lee JM; Choi KC; Kim HC; Yoo JY; Lee YH; Yoon HG
FEBS Lett; 2009 Jun; 583(12):1880-6. PubMed ID: 19481544
[TBL] [Abstract][Full Text] [Related]
4. A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer.
Kim JY; Banerjee T; Vinckevicius A; Luo Q; Parker JB; Baker MR; Radhakrishnan I; Wei JJ; Barish GD; Chakravarti D
Mol Cell; 2014 May; 54(4):613-25. PubMed ID: 24793694
[TBL] [Abstract][Full Text] [Related]
5. MLL5, a histone modifying enzyme, regulates androgen receptor activity in prostate cancer cells by recruiting co-regulators, HCF1 and SET1.
Lee KH; Kim BC; Jeong CW; Ku JH; Kim HH; Kwak C
BMB Rep; 2020 Dec; 53(12):634-639. PubMed ID: 33050986
[TBL] [Abstract][Full Text] [Related]
6. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
Kang Z; Jänne OA; Palvimo JJ
Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
[TBL] [Abstract][Full Text] [Related]
7. KAT8 Regulates Androgen Signaling in Prostate Cancer Cells.
Kim JY; Yu J; Abdulkadir SA; Chakravarti D
Mol Endocrinol; 2016 Aug; 30(8):925-36. PubMed ID: 27268279
[TBL] [Abstract][Full Text] [Related]
8. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
9. Dynamic methylation of histone H3 at lysine 4 in transcriptional regulation by the androgen receptor.
Kim J; Jia L; Tilley WD; Coetzee GA
Nucleic Acids Res; 2003 Dec; 31(23):6741-7. PubMed ID: 14627807
[TBL] [Abstract][Full Text] [Related]
10. KDM1A triggers androgen-induced miRNA transcription via H3K4me2 demethylation and DNA oxidation.
Yang S; Zhang J; Zhang Y; Wan X; Zhang C; Huang X; Huang W; Pu H; Pei C; Wu H; Huang Y; Huang S; Li Y
Prostate; 2015 Jun; 75(9):936-46. PubMed ID: 25728837
[TBL] [Abstract][Full Text] [Related]
11. Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation.
Sen A; De Castro I; Defranco DB; Deng FM; Melamed J; Kapur P; Raj GV; Rossi R; Hammes SR
J Clin Invest; 2012 Jul; 122(7):2469-81. PubMed ID: 22684108
[TBL] [Abstract][Full Text] [Related]
12. Histone H4 Lys 20 methyltransferase SET8 promotes androgen receptor-mediated transcription activation in prostate cancer.
Yao L; Li Y; Du F; Han X; Li X; Niu Y; Ren S; Sun Y
Biochem Biophys Res Commun; 2014 Jul; 450(1):692-6. PubMed ID: 24937452
[TBL] [Abstract][Full Text] [Related]
13. Gene-specific modulation of TAF10 function by SET9-mediated methylation.
Kouskouti A; Scheer E; Staub A; Tora L; Talianidis I
Mol Cell; 2004 Apr; 14(2):175-82. PubMed ID: 15099517
[TBL] [Abstract][Full Text] [Related]
14. Poly (A) Binding Protein Cytoplasmic 1 Is a Novel Co-Regulator of the Androgen Receptor.
Eisermann K; Dar JA; Dong J; Wang D; Masoodi KZ; Wang Z
PLoS One; 2015; 10(7):e0128495. PubMed ID: 26176602
[TBL] [Abstract][Full Text] [Related]
15. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
16. Human heterochromatin protein 1 isoform HP1beta enhances androgen receptor activity and is implicated in prostate cancer growth.
Shiota M; Song Y; Yokomizo A; Tada Y; Kuroiwa K; Eto M; Oda Y; Inokuchi J; Uchiumi T; Fujimoto N; Seki N; Naito S
Endocr Relat Cancer; 2010 Jun; 17(2):455-67. PubMed ID: 20308360
[TBL] [Abstract][Full Text] [Related]
17. c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.
Barfeld SJ; Urbanucci A; Itkonen HM; Fazli L; Hicks JL; Thiede B; Rennie PS; Yegnasubramanian S; DeMarzo AM; Mills IG
EBioMedicine; 2017 Apr; 18():83-93. PubMed ID: 28412251
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
Powell SM; Christiaens V; Voulgaraki D; Waxman J; Claessens F; Bevan CL
Endocr Relat Cancer; 2004 Mar; 11(1):117-30. PubMed ID: 15027889
[TBL] [Abstract][Full Text] [Related]
19. p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.
Clark EL; Hadjimichael C; Temperley R; Barnard A; Fuller-Pace FV; Robson CN
PLoS One; 2013; 8(1):e54150. PubMed ID: 23349811
[TBL] [Abstract][Full Text] [Related]
20. Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2.
Mukhopadhyay NK; Kim J; You S; Morello M; Hager MH; Huang WC; Ramachandran A; Yang J; Cinar B; Rubin MA; Adam RM; Oesterreich S; Di Vizio D; Freeman MR
Oncogene; 2014 Jun; 33(25):3235-45. PubMed ID: 23893242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
